I think the fines and penalties and timeframe of a final decision are all secondary to the real issue here: BioElectronics operates at a loss and needs money right NOW to continue operations.
The A/S increase from 11 billion to 15 billion makes it OBVIOUS that they were planning to continue their strategy of selling unregistered shares.
The SEC made it clear that if they try that again the SEC will shut them down.
There's nothing "funny" about that. Nobody at BIEL is LOL.